Lantz Financial LLC Sells 1,727 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Lantz Financial LLC lowered its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 9.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 15,727 shares of the pharmacy operator’s stock after selling 1,727 shares during the quarter. Lantz Financial LLC’s holdings in Walgreens Boots Alliance were worth $147,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. First Financial Corp IN grew its holdings in shares of Walgreens Boots Alliance by 49.2% in the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 885 shares during the period. TD Private Client Wealth LLC grew its holdings in Walgreens Boots Alliance by 8,670.3% during the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 3,208 shares during the period. Sentry Investment Management LLC bought a new stake in Walgreens Boots Alliance during the third quarter valued at about $30,000. Eastern Bank bought a new stake in Walgreens Boots Alliance during the third quarter valued at about $33,000. Finally, Strategic Investment Solutions Inc. IL bought a new stake in Walgreens Boots Alliance during the second quarter valued at about $34,000. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

NASDAQ:WBA opened at $11.87 on Friday. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $23.76. The business’s 50-day moving average is $9.86 and its 200 day moving average is $9.88.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same period in the previous year, the business earned $0.66 earnings per share. On average, research analysts expect that Walgreens Boots Alliance, Inc. will post 1.59 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts have issued reports on WBA shares. Truist Financial boosted their price target on Walgreens Boots Alliance from $10.00 to $13.00 and gave the company a “hold” rating in a report on Thursday, January 16th. Jefferies Financial Group cut their price target on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a report on Wednesday, October 23rd. TD Cowen cut their price target on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday, October 22nd. Morgan Stanley cut their price target on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a report on Friday, October 11th. Finally, Bank of America boosted their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research report on Monday, January 13th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $13.27.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.